TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
B HALL STRATEGIES, LLC	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	6

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	5
Medicare/Medicaid	Medicare/Medicaid	2

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · third_quarter · Firm: B HALL STRATEGIES, LLC

Cited source text and reported amounts

Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R.4299